These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8182271)

  • 1. The immune response to different doses of inactivated hepatitis A vaccine.
    Jilg W; Bittner R; Schätzl H; Rasshofer R; Schmidt M; Deinhardt F
    J Hepatol; 1993; 18 Suppl 2():S38-40. PubMed ID: 8182271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactogenicity and immunogenicity of three different lots of a hepatitis A vaccine.
    Theilmann L; Kallinowski B; Gmelin K; Hofmann F; Scheiermann N; Wohland B; Stickl H; Maiwald H; Moriabadi FK; Bock HL
    Vaccine; 1992; 10 Suppl 1():S132-4. PubMed ID: 1335644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination against hepatitis A: comparison of different short-term immunization schedules.
    Jilg W; Bittner R; Bock HL; Clemens R; Schätzl H; Schmidt M; André FE; Deinhardt F
    Vaccine; 1992; 10 Suppl 1():S126-8. PubMed ID: 1335642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivated hepatitis A vaccine: a safety and immunogenicity study in health professionals.
    Davidson M; Krugman S; Sandman LA
    Vaccine; 1992; 10 Suppl 1():S119-20. PubMed ID: 1335639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactogenicity and immunogenicity of inactivated hepatitis A vaccines.
    Just M; Berger R
    Vaccine; 1992; 10 Suppl 1():S110-3. PubMed ID: 1362031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the reactogenicity and immunogenicity of two different dose levels of hepatitis A vaccine in healthy children and adolescents.
    Poovorawan Y; Kosuwon P; Sutra S; Theamboonlers A; Vimolket T; Safary A
    Asian Pac J Allergy Immunol; 1998; 16(2-3):111-7. PubMed ID: 9876949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis A vaccination.
    Tong MJ; Co RL; Bellak C
    West J Med; 1993 Jun; 158(6):602-5. PubMed ID: 8393253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hepatitis A vaccination schedules on immune response.
    Tilzey AJ; Palmer SJ; Barrow S; Perry KR; Tyrell H; Safary A; Banatvala JE
    Vaccine; 1992; 10 Suppl 1():S121-3. PubMed ID: 1335640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis A vaccine in healthy adults: a comparison of immunogenicity and reactogenicity between two- and three-dose regimens.
    Lu MY; Chang MH; Tsai KS; Chen DS
    Vaccine; 1999 Jan; 17(1):26-30. PubMed ID: 10078604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis A vaccination: schedule for accelerated immunization.
    Müller R; Chriske H; Deinhardt F; Jilg J; Theilmann L; Hess G; Hofmann F; Hopf U; Stickl H; Maiwald H
    Vaccine; 1992; 10 Suppl 1():S124-5. PubMed ID: 1335641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity trial of inactivated hepatitis A virus vaccine in human volunteers.
    Kusov YuYu ; Elbert LB; Nelga IV; Grishina GK; Dunaevski OA; Kharin NV; Maslov YuN ; Drozdov SG; Balayan MS
    Vaccine; 1991 Aug; 9(8):540-1. PubMed ID: 1663301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of virus strain and antigen dose on immunogenicity and reactogenicity of an inactivated hepatitis A vaccine.
    Goubau P; Van Gerven V; Safary A; Delem A; Knops J; D'Hondt E; André FE; Desmyter J
    Vaccine; 1992; 10 Suppl 1():S114-8. PubMed ID: 1335638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous vaccination against hepatitis A and B: results of a controlled study.
    Ambrosch F; André FE; Delem A; D'Hondt E; Jonas S; Kunz C; Safary A; Wiedermann G
    Vaccine; 1992; 10 Suppl 1():S142-5. PubMed ID: 1335647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine: rationale and summary of findings.
    André FE; D'Hondt E; Delem A; Safary A
    Vaccine; 1992; 10 Suppl 1():S160-8. PubMed ID: 1335652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response after hepatitis A vaccination in haemodialysis patients: comparison with hepatitis B vaccination.
    Kuramoto I; Fujiyama S; Matsushita K; Sato T
    J Gastroenterol Hepatol; 1994; 9(3):228-31. PubMed ID: 8054520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and laboratory observations following oral or intramuscular administration of a live attenuated hepatitis A vaccine candidate.
    Sjogren MH; Purcell RH; McKee K; Binn L; Macarthy P; Ticehurst J; Feinstone S; Caudill J; See A; Hoke C
    Vaccine; 1992; 10 Suppl 1():S135-7. PubMed ID: 1335645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An inactivated hepatitis A viral vaccine of cell culture origin.
    Provost PJ; Hughes JV; Miller WJ; Giesa PA; Banker FS; Emini EA
    J Med Virol; 1986 May; 19(1):23-31. PubMed ID: 3009703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and immunogenicity of hepatitis A vaccine in healthy adult volunteers.
    Horng YC; Chang MH; Lee CY; Safary A; Andre FE; Chen DS
    J Gastroenterol Hepatol; 1993; 8(4):338-41. PubMed ID: 8397010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and safety of an inactivated hepatitis A vaccine amongst Singaporeans.
    Guan R; Ng HS; Fock KM; Ho KY; Yap I; Kang JY; Chow WC; Chew CN; Ng C; Teo CJ
    Southeast Asian J Trop Med Public Health; 1995 Jun; 26(2):268-71. PubMed ID: 8629058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization of seronegative infants with hepatitis A vaccine (HAVRIX; SKB): a comparative study of two dosing schedules.
    Troisi CL; Hollinger FB; Krause DS; Pickering LK
    Vaccine; 1997 Oct; 15(15):1613-7. PubMed ID: 9364691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.